CSBR vs LIN · P/E 16, rev $56.9M vs P/E 34, rev $33.99B
Champions Oncology Inc (CSBR) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the CSBR and LIN stock pages for the full models.
Not investment advice.